Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00120237
Status:
COMPLETED
Last Update Posted:
2009-03-19
First Post:
2005-07-07
Brief Title:
Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan
Sponsor:
Gynuity Health Projects
Organization:
Gynuity Health Projects
Study Overview
Official Title:
A Placebo-Controlled Randomized Trial of Misoprostol in the Management of the Third Stage of Labor in the Home Delivery Setting in Rural Pakistan
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan Traditional birth attendants assisting home deliveries will administer study tablets 600 mcg oral misoprostol or placebo in the third stage of labor to women participating in the trial Blood loss hemoglobin levels side effects and other variables will be evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None